BlackRock’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Sell |
8,002,689
-99,967
| -1% | -$1.7M | ﹤0.01% | 1834 |
|
|
2025
Q1 | $158M | Buy |
8,102,656
+430,717
| +6% | +$8.41M | ﹤0.01% | 1719 |
|
|
2024
Q4 | $190M | Sell |
7,671,939
-76,325
| -1% | -$1.89M | ﹤0.01% | 1686 |
|
|
2024
Q3 | $190M | Buy |
7,748,264
+113,885
| +1% | +$2.79M | ﹤0.01% | 1683 |
|
|
2024
Q2 | $179M | Buy |
7,634,379
+928,753
| +14% | +$21.8M | ﹤0.01% | 1675 |
|
|
2024
Q1 | $222M | Buy |
6,705,626
+43,583
| +0.7% | +$1.44M | 0.01% | 1570 |
|
|
2023
Q4 | $181M | Buy |
6,662,043
+139,388
| +2% | +$3.79M | ﹤0.01% | 1689 |
|
|
2023
Q3 | $157M | Buy |
6,522,655
+171,879
| +3% | +$4.13M | ﹤0.01% | 1689 |
|
|
2023
Q2 | $203M | Buy |
6,350,776
+1,060,104
| +20% | +$33.8M | 0.01% | 1556 |
|
|
2023
Q1 | $162M | Buy |
5,290,672
+52,031
| +1% | +$1.59M | ﹤0.01% | 1686 |
|
|
2022
Q4 | $205M | Sell |
5,238,641
-127,258
| -2% | -$4.98M | 0.01% | 1508 |
|
|
2022
Q3 | $256M | Buy |
5,365,899
+210,215
| +4% | +$10M | 0.01% | 1295 |
|
|
2022
Q2 | $200M | Buy |
5,155,684
+1,117,493
| +28% | +$43.3M | 0.01% | 1525 |
|
|
2022
Q1 | $231M | Sell |
4,038,191
-24,603
| -0.6% | -$1.41M | 0.01% | 1559 |
|
|
2021
Q4 | $324M | Buy |
4,062,794
+542,819
| +15% | +$43.3M | 0.01% | 1367 |
|
|
2021
Q3 | $306M | Buy |
3,519,975
+345,588
| +11% | +$30.1M | 0.01% | 1379 |
|
|
2021
Q2 | $409M | Buy |
3,174,387
+82,576
| +3% | +$10.6M | 0.01% | 1188 |
|
|
2021
Q1 | $247M | Sell |
3,091,811
-67,699
| -2% | -$5.42M | 0.01% | 1575 |
|
|
2020
Q4 | $258M | Buy |
3,159,510
+931,108
| +42% | +$76M | 0.01% | 1415 |
|
|
2020
Q3 | $54.9M | Buy |
2,228,402
+903,808
| +68% | +$22.3M | ﹤0.01% | 2195 |
|
|
2020
Q2 | $37.1M | Buy |
1,324,594
+70,589
| +6% | +$1.98M | ﹤0.01% | 2393 |
|
|
2020
Q1 | $22.6M | Buy |
+1,254,005
| New | +$22.6M | ﹤0.01% | 2512 |
|